FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1821026158> ?p ?o ?g. }

• W1821026158 endingPage "1668" @default.
• W1821026158 startingPage "1657" @default.
• W1821026158 abstract "The American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol management guidelines have significantly broadened the scope of candidates eligible for statin therapy.This study evaluated the implications of the absence of coronary artery calcium (CAC) in reclassifying patients from a risk stratum in which statins are recommended to one in which they are not.MESA (Multi-Ethnic Study of Atherosclerosis) is a longitudinal study of 6,814 men and women 45 to 84 years of age without clinical atherosclerotic cardiovascular disease (ASCVD) risk at enrollment. We excluded 1,100 participants (16%) on lipid-lowering medication, 87 (1.3%) without low-density lipoprotein levels, 26 (0.4%) with missing risk factors for calculation of 10-year risk of ASCVD, 633 (9%) >75 years of age, and 209 (3%) with low-density lipoprotein <70 mg/dl from the analysis.The study population consisted of 4,758 participants (age 59 ± 9 years; 47% males). A total of 247 (5.2%) ASCVD and 155 (3.3%) hard coronary heart disease events occurred over a median (interquartile range) follow-up of 10.3 (9.7 to 10.8) years. The new ACC/AHA guidelines recommended 2,377 (50%) MESA participants for moderate- to high-intensity statins; the majority (77%) was eligible because of a 10-year estimated ASCVD risk ≥7.5%. Of those recommended statins, 41% had CAC = 0 and had 5.2 ASCVD events/1,000 person-years. Among 589 participants (12%) considered for moderate-intensity statin, 338 (57%) had a CAC = 0, with an ASCVD event rate of 1.5 per 1,000 person-years. Of participants eligible (recommended or considered) for statins, 44% (1,316 of 2,966) had CAC = 0 at baseline and an observed 10-year ASCVD event rate of 4.2 per 1,000 person-years.Significant ASCVD risk heterogeneity exists among those eligible for statins according to the new guidelines. The absence of CAC reclassifies approximately one-half of candidates as not eligible for statin therapy." @default.
• W1821026158 created "2016-06-24" @default.
• W1821026158 creator A5008531984 @default.
• W1821026158 creator A5012676647 @default.
• W1821026158 creator A5025347701 @default.
• W1821026158 creator A5033386949 @default.
• W1821026158 creator A5044318410 @default.
• W1821026158 creator A5054395583 @default.
• W1821026158 creator A5072663918 @default.
• W1821026158 creator A5075445537 @default.
• W1821026158 creator A5079665496 @default.
• W1821026158 creator A5087095202 @default.
• W1821026158 creator A5088028306 @default.
• W1821026158 creator A5089780548 @default.
• W1821026158 date "2015-10-01" @default.
• W1821026158 modified "2023-10-02" @default.
• W1821026158 title "Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines" @default.
• W1821026158 cites W118162583 @default.
• W1821026158 cites W1570847954 @default.
• W1821026158 cites W158308617 @default.
• W1821026158 cites W1743552125 @default.
• W1821026158 cites W1844872504 @default.
• W1821026158 cites W1969678022 @default.
• W1821026158 cites W1975897418 @default.
• W1821026158 cites W1979047197 @default.
• W1821026158 cites W1989252409 @default.
• W1821026158 cites W1995584725 @default.
• W1821026158 cites W2015185375 @default.
• W1821026158 cites W2033209427 @default.
• W1821026158 cites W2053760965 @default.
• W1821026158 cites W2090046314 @default.
• W1821026158 cites W2122691873 @default.
• W1821026158 cites W2127427274 @default.
• W1821026158 cites W2131985932 @default.
• W1821026158 cites W2146739537 @default.
• W1821026158 cites W2153785016 @default.
• W1821026158 cites W2156097706 @default.
• W1821026158 cites W2157241521 @default.
• W1821026158 cites W2160812379 @default.
• W1821026158 cites W2167830562 @default.
• W1821026158 cites W2168536722 @default.
• W1821026158 cites W304680890 @default.
• W1821026158 cites W4236673002 @default.
• W1821026158 cites W89627998 @default.
• W1821026158 doi "https://doi.org/10.1016/j.jacc.2015.07.066" @default.
• W1821026158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26449135" @default.
• W1821026158 hasPublicationYear "2015" @default.
• W1821026158 type Work @default.
• W1821026158 sameAs 1821026158 @default.
• W1821026158 citedByCount "369" @default.
• W1821026158 countsByYear W18210261582014 @default.
• W1821026158 countsByYear W18210261582015 @default.
• W1821026158 countsByYear W18210261582016 @default.
• W1821026158 countsByYear W18210261582017 @default.
• W1821026158 countsByYear W18210261582018 @default.
• W1821026158 countsByYear W18210261582019 @default.
• W1821026158 countsByYear W18210261582020 @default.
• W1821026158 countsByYear W18210261582021 @default.
• W1821026158 countsByYear W18210261582022 @default.
• W1821026158 countsByYear W18210261582023 @default.
• W1821026158 crossrefType "journal-article" @default.
• W1821026158 hasAuthorship W1821026158A5008531984 @default.
• W1821026158 hasAuthorship W1821026158A5012676647 @default.
• W1821026158 hasAuthorship W1821026158A5025347701 @default.
• W1821026158 hasAuthorship W1821026158A5033386949 @default.
• W1821026158 hasAuthorship W1821026158A5044318410 @default.
• W1821026158 hasAuthorship W1821026158A5054395583 @default.
• W1821026158 hasAuthorship W1821026158A5072663918 @default.
• W1821026158 hasAuthorship W1821026158A5075445537 @default.
• W1821026158 hasAuthorship W1821026158A5079665496 @default.
• W1821026158 hasAuthorship W1821026158A5087095202 @default.
• W1821026158 hasAuthorship W1821026158A5088028306 @default.
• W1821026158 hasAuthorship W1821026158A5089780548 @default.
• W1821026158 hasBestOaLocation W18210261581 @default.
• W1821026158 hasConcept C119060515 @default.
• W1821026158 hasConcept C126322002 @default.
• W1821026158 hasConcept C164705383 @default.
• W1821026158 hasConcept C2776839432 @default.
• W1821026158 hasConcept C2778213512 @default.
• W1821026158 hasConcept C2779134260 @default.
• W1821026158 hasConcept C2908647359 @default.
• W1821026158 hasConcept C2909478654 @default.
• W1821026158 hasConcept C2909917808 @default.
• W1821026158 hasConcept C2994533308 @default.
• W1821026158 hasConcept C71924100 @default.
• W1821026158 hasConcept C99454951 @default.
• W1821026158 hasConceptScore W1821026158C119060515 @default.
• W1821026158 hasConceptScore W1821026158C126322002 @default.
• W1821026158 hasConceptScore W1821026158C164705383 @default.
• W1821026158 hasConceptScore W1821026158C2776839432 @default.
• W1821026158 hasConceptScore W1821026158C2778213512 @default.
• W1821026158 hasConceptScore W1821026158C2779134260 @default.
• W1821026158 hasConceptScore W1821026158C2908647359 @default.
• W1821026158 hasConceptScore W1821026158C2909478654 @default.
• W1821026158 hasConceptScore W1821026158C2909917808 @default.
• W1821026158 hasConceptScore W1821026158C2994533308 @default.
• W1821026158 hasConceptScore W1821026158C71924100 @default.
• W1821026158 hasConceptScore W1821026158C99454951 @default.

• next